EF
TGTX icon

Empowered Funds’s TG Therapeutics TGTX Stock Holding History

Empowered Funds’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.84M Buy
85,429
+28,452
+50% +$848K 0.02% 908
2025
Q4 		$1.7M Buy
+56,977
New +$1.86M 0.03% 526
2025
Q1 		– Sell
-49,267
Closed -$1.48M – 1787
2024
Q4 		$1.48M Buy
49,267
+2,836
+6% +$81.4K 0.02% 847
2024
Q3 		$1.09M Buy
46,431
+1,386
+3% +$30.3K 0.02% 878
2024
Q2 		$801K Buy
+45,045
New +$719K 0.01% 921
2021
Q2 		– Sell
-55,545
Closed -$2.89M – 297
2021
Q1 		$2.89M Hold
55,545
– – 0.55% 32
2020
Q4 		$2.89M Buy
+55,545
New +$1.88M 0.55% 32

Other funds holding TGTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return